DSIP

Delta Sleep-Inducing Peptide (DSIP) is a naturally occurring nonapeptide described as a neuromodulator of sleep architecture and stress physiology. The protocol highlights that DSIP administration is associated with increases in delta-wave (slow-wave) sleep on EEG, suggesting an effect on deep non-REM sleep initiation and maintenance. It is also described as crossing the blood–brain barrier and interacting with central sleep-regulatory circuitry, potentially enhancing inhibitory tone or stabilizing sleep-promoting networks. Beyond sleep, DSIP is linked to modulation of the hypothalamic–pituitary–adrenal (HPA) axis: the page notes attenuation of ACTH and corticosterone responses under stress, which may translate to calmer stress reactivity and improved sleep continuity. A key differentiator emphasized is normalization of sleep patterns without typical next-day sedation reported with some hypnotics. In short, DSIP is presented as a sleep-depth and stress-response modulator.